dentists. Guidelines for preventing infective endocarditis related to medical procedures have been developed by professional societies like the American Heart Association (AHA) since the 1950s. The guidelines were empiric, formulated based more on pathophysiology and expert opinion and less on clinical evidence. Since both endothelial injury and a precipitating event causing bacteremia are requisite for development of infective endocarditis, patients with risk factors for endothelial injury undergoing medical procedures which can cause transient bacteremia were construed to be at high risk for developing infective endocarditis. Since certain groups of bacteria (Streptococci, Staphylococci, Enterococci, etc.) are commonly known to adhere to nonbacterial thrombotic endocarditis (NBTE) causing infective endocarditis, procedures which caused bacteremia from these organisms were considered as high risk procedures. Prevention of bacteremia with appropriate antibiotics could in theory prevent or reduce bacteremia and prevent bacterial colonization of NBTE and thereby minimize the risk of infective endocarditis (figure 1). The bone of contention among the various guidelines and revisions is defining the patient population at high risk for cardiac endothelial injury and procedures with high risk for bacteremia.
Evidence-Based Approach to Infective Endocarditis Prophylaxis: Do no Harm!
While in theory, use of appropriate antibiotic prophylaxis for bacteremia causing procedures in patients with cardiac risk factors should lead to decreased incidence of infective endocarditis, this has not borne out in studies. Several factors contribute to the failure of this seemingly sound empirical approach. It is common knowledge and studies have shown that procedures like dental extraction cause bacteremia; so do everyday activities like brushing teeth. While the degree of bacteremia caused by routine activities at a particular point in time may or may not be on the Rationale for new antibiotic prophylaxis guidelines Page 4 same magnitude as dental procedures, the overall burden of bacteremia over extended periods of time from daily activities would definitely surpass the transient bacteremia seen after medical procedures. The cumulative exposure to bacteremia from routine daily activities in 1 year may be as high as 5.6 x 10 6 times greater as that resulting from a single tooth extraction. 5 Studies have
shown only a small fraction, if at all any, of the infective endocarditis cases were probably caused by dental procedures. 6, 7 Another weak link is the efficacy of antibiotic prophylaxis in preventing or reducing bacteremia, as this form is the main argument for empiric approach. The evidence for bacteremia reduction or prevention by antibiotic prophylaxis is conflicting. [8] [9] [10] [11] Even studies which show reduction in bacteremia do not show reduction in infective endocarditis. 8, 9 While studies in dental procedures have failed to show a clear benefit for antibiotic prophylaxis, studies in other procedures (respiratory, gastrointestinal, and genitourinary) are very limited.
Evidence on the cost effectiveness of antibiotic prophylaxis for at-risk patients undergoing interventional procedures is contradictory as well. [12] [13] [14] [15] [16] Without any clear evidence of benefit, the traditional empiric approach for antibiotic prophylaxis has been in vogue, thus far, primarily thanks to the apprehension about the serious nature of infective endocarditis among physicians, as well as among patients, reinforced by past recommendations from professional societies.
Emergence of antibiotic resistance as a significant public health concern combined with the risk of antibiotic-related adverse effects, albeit infrequent, such as anaphylaxis, Clostridium difficile colitis, etc., has prompted a steady move towards an evidence-based approach to infective endocarditis prophylaxis. This is reflected in the recommendations of different professional societies in the last decade or so (table 1) . 
National Institute for Health and Clinical Excellence (NICE) Guidance
NICE guidelines published in 2008 made an even more radical departure from the past (http://www.nice.org.uk/nicemedia/pdf/CG64NICEguidance.pdf). They do not recommend antibiotic prophylaxis for dental, or non-dental procedures (e.g., respiratory, gastrointestinal, and genitourinary). 21 If a person at risk for infective endocarditis is receiving antibiotic therapy because they are undergoing a gastrointestinal or genitourinary procedure at a site with a suspected infection, antibiotics used should cover organisms that cause infective endocarditis The cause for dissent arises from two important aspects, one being the major departure from traditional recommendations. The second and probably the most intriguing aspect is that two professional societies (BSAC and AHA) and NICE have come with three significantly different sets of recommendations, even though all three recognize the paucity of evidence and aim to narrow the indication for prophylaxis. Based on the same body of evidence (lack of evidence for benefit in dental procedures and lack of good epidemiological data for non-dental procedures), BSAC recommends prophylaxis for dental and non-dental (including gastrointestinal and genitourinary), AHA recommends prophylaxis for only dental and respiratory procedures and not gastrointestinal or genitourinary procedures, and NICE recommends prophylaxis for none of the procedures. While these three guidelines differ in their details, they all point toward a general trend against empiric use of antibiotic prophylaxis for infective endocarditis. With the rampant increase in incidence of multi-drug resistant organisms, an evidence based approach to antibiotic prophylaxis is a healthy trend. Establishing the efficacy and safety of antibiotic prophylaxis with well designed prospective studies, a yardstick used for acceptance of most medical interventions, should be required for antibiotic prophylaxis as well, considering the significant public health concerns discussed earlier. Subsequent to publishing these guidelines, a Cochrane database review on antibiotics for prophylaxis of bacterial endocarditis in dentistry showed no evidence as to whether penicillin prophylaxis is effective or ineffective against bacterial endocarditis in people at risk who are about to undergo an invasive dental procedure.
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Conclusion
With the NICE guidance, infective endocarditis prophylaxis has come full circle. In the latter half of the 20 th century, regular revisions for infective endocarditis prophylaxis guidelines added more cardiac risk conditions and risk groups, more at risk procedures and more antibiotic regimens, adding to the complexity faced by a primary physician in both applying these recommendations to an individual patient and also in explaining the benefits and potential harm to the patient. This created potential for misgivings in physician-patient relationships and medico-legal pitfalls. The newer guidelines are much simpler to follow and could potentially overcome this serious concern. However, explaining these drastic changes to an old returning patient and to referral physicians who are more accustomed to old recommendations would be 
Author Affiliations
Prabhakaran P. Gopalakrishnan Table 2 . American Heart Association infective endocarditis prophylaxis recommendations.
Cardiac conditions in which prophylaxis is reasonable
• Prosthetic cardiac valve or prosthetic material used for cardiac valve repair • Previous infective endocarditis • Congenital heart disease (CHD)
• Post-cardiac transplant valvulopathy -Unrepaired cyanotic CHD, including shunts and conduits -Completely repaired congenital heart defect with prosthetic material or device, during the first 6 months after the procedure -Repaired CHD with residual defects at or adjacent to site of prosthetic patch or device inhibiting endothelialization • Post-cardiac transplant valvulopathy
Procedures for which prophylaxis is reasonable (only in patients with above listed high risk cardiac conditions)
• All dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of oral mucosa • Invasive procedure of the respiratory tract that involves incision or biopsy of respiratory mucosa • Procedures involving infected skin, skin structures, or musculoskeletal tissue
Antibiotic prophylaxis solely to prevent infective endocarditis is not recommended for gastrointestinal or genitourinary tract procedures
Reproduced with permission: Wilson et al.
4 Table 4 . NICE guidance for infective endocarditis prophylaxis.
Cardiac conditions at high risk for infective endocarditis:
• Acquired valvular heart disease with stenosis or regurgitation • Valve replacement • Structural congenital heart disease, including surgically corrected or palliated structural conditions, but excluding isolated atrial septal defect, fully repaired ventricular septal defect or fully repaired patent ductus arteriosus, and closure devices that are judged to be endothelialized • Previous infective endocarditis • Hypertrophic cardiomyopathy Antibiotic prophylaxis is not recommended:
• For people undergoing dental procedures • For people undergoing non-dental procedures at these sites (upper and lower gastrointestinal; genitourinary tracturological, gynecological and obstetric procedures, and childbirth; upper and lower respiratory tract -includes ear, nose and throat procedures and bronchoscopy)
Chlorhexidine mouthwash is not recommended for infective endocarditis prophylaxis for dental procedures.
Infections in patients at risk for infective endocarditis should be promptly treated to reduce risk of infective endocarditis developing. Antibiotic therapy used for gastrointestinal or genitourinary procedures at a site with suspected infection in patients at risk of infective endocarditis, should cover organisms causing infective endocarditis.
Patients should be educated on benefits and risks of antibiotic prophylaxis, recommendations against antibiotic prophylaxis, importance of oral hygiene, symptoms of infective endocarditis and risks of invasive procedures including non-medical procedures like body piercing and tattooing.
Modified and adapted from prophylaxis against infective endocarditis: NICE guidance, 2008. 
